Previously, we demonstrated that three key molecular features of glioma, telomerase (TERT) promoter mutation, IDH mutation, and 1p/19q codeletion, are sufficient to create an integrated molecular classification that defines five principal groups of glioma with characteristic distributions of age at diagnosis, clinical behavior, acquired genetic alterations, and associated germline variants [4]. Here, IDH1 is linked to glioma.